BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

XELODA Pages on BioPortfolio:

Biotechnology News XELODA Search
_ Landmark study in The Lancet Oncology shows capecitabine (Xeloda) combination therapy ... Adding capecitabine (Xeloda) to standard adjuvant chemotherapy ...
http://www.bioportfolio.co.uk/XELODA-news.htm...

BioPortfolio - Xeloda
Press Releases About Xeloda: BioPortfolio Logo. Driven by the Launch of Targeted Agents, the Gastric Cancer Drug Market Will More Than Double to Nearly $1.5 ...
http://www.bioportfolio.com/indepth/Xeloda.html...

BioPortfolio.com - BioWeb Osteomyelitis Bone Search
... with Taxotere Metastatic breast cancer in combo with Xeloda metastatic breast cancer w Enhanzyn adjuvant Metastatic cancers metastatic colorectal
cancer ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Roche - New Overall Survival Study Results Confirm ...
Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin ( XELOX) is Comparable to. FOLFOX-4 for the First-Line Treatment of . ...
http://www.bioportfolio.com/news/New_Overall_Survival_Study_...

Biotechnology News Search
The results of a large Phase III randomised study in women with early breast cancer has shown that adding capecitabine (Xeloda) to a standard treatment ...
http://www.bioportfolio.co.uk/Biotechnology_News_from_Pharma...

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd ...
Roche (coverage of Xeloda, Avastin, MabThera, Herceptin, Tarceva and pipeline drugs). * Sanofi-Aventis (coverage of Taxotere, Eloxatine and others) ...
http://www.bioportfolio.com/cgi-bin/acatalog/The_World_Marke...

Biotechnology News breast cancer Search
Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R)) Combination Therapy Reduces Early Breast Cancer Recurrence ...
http://www.bioportfolio.co.uk/breast%20cancer-news.htm...

BioPortfolio - University of Nebraska Lincoln Center for ...
Capecitabine (Xeloda(R)) · Combination Therapy · Reduces Early Breast · Cancer Recurrence. 11th November, 2009. Finland, November 11 ...
http://www.bioportfolio.com/biocorporate/10622-University+of...

Biotechnology News FLUOROURACIL Search
Adding capecitabine (Xeloda) to standard adjuvant chemotherapy significantly reduced the risk of breast cancer recurrence, but the cost was a substantial ...
http://www.bioportfolio.co.uk/FLUOROURACIL-news.htm...

BioPortfolio News: - Capecitabine Added to Standard...
23 Sep 2009 ... Germany, show that adding capecitabine (Xeloda(R)) to anthracycline- and taxane-containing regimens prior to surgery (neoadjuvant ...
http://www.bioportfolio.com/news/Capecitabine_Added_to_Stand...

Results from other life science and pharmaceutical sites:

Capecitabine - Wikipedia, the free encyclopedia
Capecitabine (INN) (pronounced /keɪpˈsaɪtəbiːn/) (Xeloda, Roche) is an orally- administered chemotherapeutic agent used in the treatment of metastatic breast
...
http://en.wikipedia.org/wiki/Capecitabine...

Genentech: Medicines: Xeloda
Skip to Content for Xeloda Menu for Xeloda About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu ...
http://www.gene.com/gene/products/information/xeloda/...

Roche - Product-details: Xeloda (Capecitabine)
Xeloda (Capecitabine). Doctor with Patient. Used to treat patients with colorectal, breast, or colon cancer. Please select your country, www.xeloda.
roche. ...
http://www.roche.com/products/product-details.htm?type=produ...

Xeloda Tablets
stabilized on anticoagulants at the time XELODA was introduced. ... XELODA is supplied as biconvex, oblong film-coated tablets for oral administration. ...
http://www.gene.com/gene/products/information/xeloda/pdf/pi....

Xeloda in combination with oxaliplatin shown to be effective in ...
20 Jul 2009 ... “While Xeloda is already approved for the treatment of early-stage ... Xeloda is a highly effective oral chemotherapy drug that can be used ...
http://www.roche.com/med-cor-2009-07-20-e.pdf...

1 Patient Information 2 XELODA (capecitabine) TABLETS 3 Rx only 4 ...
important information about XELODA. However, this information does not take the ... are allergic to capecitabine or to any of the ingredients in XELODA ...
http://www.gene.com/gene/products/information/xeloda/pdf/ppi...

Xeloda - DailyMed: About DailyMed
XELODA Warfarin Interaction: Patients receiving concomitant capecitabine and oral coumarin-derivative anticoagulant therapy should have their anticoagulant
...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=630...

Roche - Landmark study in The Lancet Oncology shows Xeloda reduces ...
11 Nov 2009 ... Large, independent phase III randomised study in women with early breast cancer shows that adding Xeloda (capecitabine) to a treatment ...
http://www.roche.com/media/media_releases/med-div_2009-11-11...

Xeloda(R) Tablets (150 mg)
Xeloda is a pharmacological product used in the treatment of colorectal and breast cancer. ... Hand-and-Foot Syndrome can occur when taking Xeloda. In time,
...
http://www.gene.com/gene/products/information/msds/xeloda/MS...

Roche - EU Grants Broad Approval of Xeloda for Patients with ...
4 Feb 2008 ... Roche announced today that the European Commission has approved its oral chemotherapy Xeloda (capecitabine) for the treatment of metastatic ...
http://www.roche.com/investors/ir_update/inv-update-2008-02-...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.